Extract from our M&A Insights

Read more about our Nordic and DACH M&A Insights services including the M&A Portal and Private Equity Portfolio Tracker.
Nordic Capital sells its remaining shares in global medical products and technology company ConvaTec
May 3, 2018

Nordic Capital has sold its remaining shares in ConvaTec Group Plc. The remaining shareholding of 143,158,828 ordinary shares (representing approximately 7.3% of the issued share capital) in ConvaTec was sold on May 3, 2018, through a book-building process which generated strong investor interest. The price was 220 pence per ordinary share, raising gross proceeds of GBP 315 million.

ⓘ This story was originally featured in our daily Nordic M&A Newsletter - we publish some of the newsletter content with delay through our M&A Newsletter Library. If you would like more insights on this deal or industry then send us an email at requests@nordicknowledgepartners.com